MedPath

VR-assisted CBT for Adolescents With Psychosis

Not Applicable
Recruiting
Conditions
Psychotic Disorders
Interventions
Behavioral: An intervention development study
Behavioral: A randomized feasibility study
Behavioral: A single-case study
Registration Number
NCT04586868
Lead Sponsor
Haukeland University Hospital
Brief Summary

Psychotic disorders typically emerge during late adolescence or early adulthood. Patients, who are diagnosed with a psychotic disorder before turning 18 years, are defined as early onset psychosis patients (EOP). Relative to adult patients, these patients show a worse long-term prognoses. Social impairment present a major barrier towards recovery, and thus and important issue to address in treatment. Cognitive behavioral therapy (CBT) is the recommended psychological treatment for psychotic disorders. As part of the therapy, the patient does an exposure-based training in a social environment. This type of training has several limitations for patients with psychosis. The last decade there has been a growing interest in using virtual reality (VR) to understand and treat various psychological disorders. There is a lack of research on VR-interventions for EOP patients. This study will assess the acceptability, tolerability, feasibility and clinical efficacy of a novel VR-assisted CBT interventions for adolescents with psychosis.

Detailed Description

This study adhere to the model for research made by the international Virtual Reality Clinical Outcomes Research Experts groups (VR-CORE). The study consist of three sub-studies. First a qualitative study assessing the acceptability for VR among adolescence with psychosis. Secondly, a randomized study of the feasibility of virtual reality environment for adolescents with psychosis. Third, assessing the clinical efficacy of a novel VR-assisted CBT interventions for adolescents with psychosis, through a non-randomized single-case study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Suffering from a psychotic disorder (ICD-10 WHO)
  • In stable clinical condition (i.e. not hospitalized)
  • Being able to speak Norwegian or a Scandinavian language, or English
  • Able to provide informed consent.
Exclusion Criteria
  • Primary neurological or endocrinological disorder
  • Started a "transfer-process" to Department of Adult Psychiatry.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
A psychotic disorderAn intervention development studyPatients, age 13-18 years old, diagnosed with a psychotic disorder (WHO ICD-10 )
A psychotic disorderA randomized feasibility studyPatients, age 13-18 years old, diagnosed with a psychotic disorder (WHO ICD-10 )
A psychotic disorderA single-case studyPatients, age 13-18 years old, diagnosed with a psychotic disorder (WHO ICD-10 )
Primary Outcome Measures
NameTimeMethod
Acceptability for a virtual reality intervention5 months

Semi-structured interview

Social paranoia1 week before and 1 week after treatment.

State Social Paranoia Scale (SSPS)

Social self-efficacy1 week before, and 10 minutes after treatment.

Adolescent self-efficacy scale (S-EFF)

Social interaction and social phobia1 week before, and 10 minutes after treatment.

Short Form Social Interaction Anxiety Scale/Social Phobia Scale (SIAS-6/SPS-6)

Secondary Outcome Measures
NameTimeMethod
Self-esteem1 week before, and 10 minutes after treatment.

Rosenberg Self-Esteem scale (RSES)

The experience of presence10 minutes after treatment

Gatineau Presence Questionnaire (GPQ)

Psychotic symptoms1 week before and 1 week after treatment.

Brief Psychiatric Rating Scale (BPRS)

Unwanted side effect10 minutes before and 10 minutes after treatment

Virtual Reality Sickness Questionnaire (VRSQ)

Trial Locations

Locations (1)

Haukeland university hospital

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath